Effects of iatrogenic myocardial injury on coronary microvascular function in patients undergoing radiofrequency catheter ablation of atrial fibrillation

Circulation: Arrhythmia and Electrophysiology

Volumn 6, Issue 2, 2013, Pages 318-326

  Lim, Hong Euy ^a   Choi, Cheol Ung ^a   Na, Jin Oh ^a   Choi, Jong Il ^a   Kim, Seong Hwan ^b   Kim, Jin Won ^a   Kim, Eung Ju ^a   Han, Seong Woo ^a   Park, Sang Weon ^a   Rha, Seung Woon ^a   Park, Chang Gyu ^a   Seo, Hong Seog ^a   Oh, Dong Joo ^a   Hwang, Chun ^c   Kim, Young Hoon ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c UTAH VALLEY REGIONAL MEDICAL CENTER   (United States)

Author keywords

Atrial fibrillation; Catheter ablation; Coronary microvascular function; Index of microvascular resistance

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATINE KINASE MB; MYOGLOBIN; NITRIC OXIDE; TROPONIN T;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CARDIAC PATIENT; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY VASCULAR RESISTANCE; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPH; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART CYCLE; HEART ELECTROPHYSIOLOGY; HEART MUSCLE INJURY; HOLTER MONITORING; HUMAN; IATROGENIC DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; SUPRAVENTRICULAR TACHYCARDIA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ATRIAL FIBRILLATION; CATHETER ABLATION; CORONARY CIRCULATION; CORONARY VESSELS; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HEART INJURIES; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 84878063456     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.000282     Document Type: Article

References (26)

1. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, Skanes A, Ambrogi F, Biganzoli E. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:32-38.
2. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012;9:632-696.e21.
3. Joshi S, Choi AD, Kamath GS, Raiszadeh F, Marrero D, Badheka A, Mittal S, Steinberg JS. Prevalence, predictors, and prognosis of atrial fibrillation early after pulmonary vein isolation: findings from 3 months of continuous automatic ECG loop recordings. J Cardiovasc Electrophysiol. 2009;20:1089-1094.
4. Belhassen B. Corticosteroid therapy after catheter ablation of atrial fibrillation for an authentic "blanking period". J Am Coll Cardiol. 2010;56:1473-1475.
5. Link MS. What is the "Blanking Period"? J Cardiovasc Electrophysiol. 2009;20:1095-1096.
6. Kühne M, Suter Y, Altmann D, Ammann P, Schaer B, Osswald S, Sticherling C. Cryoballoon versus radiofrequency catheter ablation of paroxysmal atrial fibrillation: biomarkers of myocardial injury, recurrence rates, and pulmonary vein reconnection patterns. Heart Rhythm. 2010;7:1770-1776.
7. Hu YF, Yeh HI, Tsao HM, Tai CT, Lin YJ, Chang SL, Lo LW, Tuan TC, Tzeng CH, Huang SH, Lin YK, Chen SA. Impact of circulating monocyte CD36 level on atrial fibrillation and subsequent catheter ablation. Heart Rhythm. 2011;8:650-656.
8. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830-840.
9. Ng MK, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation. 2006;113:2054-2061.
10. Lim HS, Yoon MH, Tahk SJ, Yang HM, Choi BJ, Choi SY, Sheen SS, Hwang GS, Kang SJ, Shin JH. Usefulness of the index of microcirculatory resistance for invasively assessing myocardial viability immediately after primary angioplasty for anterior myocardial infarction. Eur Heart J. 2009;30:2854-2860.
11. McGeoch R, Watkins S, Berry C, Steedman T, Davie A, Byrne J, Hillis S, Lindsay M, Robb S, Dargie H, Oldroyd K. The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol Cardiovasc Interv. 2010;3:715-722.
12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W; American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79-108.
13. Knaapen P, Camici PG, Marques KM, Nijveldt R, Bax JJ, Westerhof N, Götte MJ, Jerosch-Herold M, Schelbert HR, Lammertsma AA, van Rossum AC. Coronary microvascular resistance: methods for its quantification in humans. Basic Res Cardiol. 2009;104:485-498.
14. Melikian N, Kearney MT, Thomas MR, De Bruyne B, Shah AM, MacCarthy PA. A simple thermodilution technique to assess coronary endothelium-dependent microvascular function in humans: validation and comparison with coronary flow reserve. Eur Heart J. 2007;28:2188-2194.
15. Themistoclakis S, Schweikert RA, Saliba WI, Bonso A, Rossillo A, Bader G, Wazni O, Burkhardt DJ, Raviele A, Natale A. Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation. Heart Rhythm. 2008;5:679-685.
16. Choi JI, Pak HN, Park JS, Kwak JJ, Nagamoto Y, Lim HE, Park SW, Hwang C, Kim YH. Clinical significance of early recurrences of atrial tachycardia after atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2010;21:1331-1337.
17. Hussein AA, Saliba WI, Martin DO, Bhargava M, Sherman M, Magnelli-Reyes C, Chamsi-Pasha M, John S, Williams-Adrews M, Baranowski B, Dresing T, Callahan T, Kanj M, Tchou P, Lindsay BD, Natale A, Wazni O. Natural history and long-term outcomes of ablated atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4:271-278.
18. Cha YM, Wokhlu A, Asirvatham SJ, Shen WK, Friedman PA, Munger TM, Oh JK, Monahan KH, Haroldson JM, Hodge DO, Herges RM, Hammill SC, Packer DL. Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function. Circ Arrhythm Electrophysiol. 2011;4:724-732.
19. Caputo M, Urselli R, Capati E, Navarri R, Sinesi L, Furiozzi F, Ballo P, Palazzuoli A, Favilli R, Mondillo S. Usefulness of left ventricular diastolic dysfunction assessed by pulsed tissue Doppler imaging as a predictor of atrial fibrillation recurrence after successful electrical cardioversion. Am J Cardiol. 2011;108:698-704.
20. Freestone B, Krishnamoorthy S, Lip GY. Assessment of endothelial dysfunction. Expert Rev Cardiovasc Ther. 2010;8:557-571.
21. Smedbakken L, Jensen JK, Hallén J, Atar D, Januzzi JL, Halvorsen B, Aukrust P, Ueland T. Activated leukocyte cell adhesion molecule and prognosis in acute ischemic stroke. Stroke. 2011;42:2453-2458.
22. Vrints CJ. Pathophysiology of the no-reflow phenomenon. Acute Card Care. 2009;11:69-76.
23. Rezkalla SH, Kloner RA. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv. 2008;72:950-957.
24. Lavi S, Lavi R, McConnell JP, Lerman LO, Lerman A. Lipoproteinassociated phospholipase A(2): review of its role as a marker and a potential participant in coronary endothelial dysfunction. Mol Diagn Ther. 2007;11:219-226.
25. Yang EH, McConnell JP, Lennon RJ, Barsness GW, Pumper G, Hartman SJ, Rihal CS, Lerman LO, Lerman A. Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol. 2006;26:106-111.
26. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357-2368.